Autobio Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Autobio Diagnostics has a total shareholder equity of CN¥8.5B and total debt of CN¥556.4M, which brings its debt-to-equity ratio to 6.6%. Its total assets and total liabilities are CN¥11.4B and CN¥2.9B respectively. Autobio Diagnostics's EBIT is CN¥1.3B making its interest coverage ratio -13.3. It has cash and short-term investments of CN¥832.2M.
Key information
6.6%
Debt to equity ratio
CN¥556.36m
Debt
| Interest coverage ratio | -13.3x |
| Cash | CN¥832.15m |
| Equity | CN¥8.49b |
| Total liabilities | CN¥2.90b |
| Total assets | CN¥11.39b |
Recent financial health updates
Recent updates
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate
Aug 09
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet
Jul 18Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?
May 21Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings
Feb 27Financial Position Analysis
Short Term Liabilities: 603658's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 603658's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥515.4M).
Debt to Equity History and Analysis
Debt Level: 603658 has more cash than its total debt.
Reducing Debt: 603658's debt to equity ratio has reduced from 34.7% to 6.6% over the past 5 years.
Debt Coverage: 603658's debt is well covered by operating cash flow (263.8%).
Interest Coverage: 603658 earns more interest than it pays, so coverage of interest payments is not a concern.